News
Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 ...
Alembic Pharma received the final approval from the USFDA for its abbreviated new drug application (ANDA) for Carbamazepine ...
Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback